SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-057283
Filing Date
2021-04-29
Accepted
2021-04-29 12:41:24
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111788d1_10q.htm 10-Q 285236
2 EXHIBIT 31.1 tm2111788d1_ex31-1.htm EX-31.1 11950
3 EXHIBIT 31.2 tm2111788d1_ex31-2.htm EX-31.2 12011
4 EXHIBIT 32.1 tm2111788d1_ex32-1.htm EX-32.1 4774
5 EXHIBIT 32.2 tm2111788d1_ex32-2.htm EX-32.2 4681
  Complete submission text file 0001104659-21-057283.txt   2296507

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT txac-20210331.xml EX-101.INS 337412
7 XBRL TAXONOMY EXTENSION SCHEMA txac-20210331.xsd EX-101.SCH 35797
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txac-20210331_cal.xml EX-101.CAL 16314
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txac-20210331_def.xml EX-101.DEF 131361
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE txac-20210331_lab.xml EX-101.LAB 247503
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txac-20210331_pre.xml EX-101.PRE 198664
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 617-778-2500
Therapeutics Acquisition Corp. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39373 | Film No.: 21868799
SIC: 2834 Pharmaceutical Preparations